Skip to main content
SpringerLink
Log in

Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Background

The purpose of this study was to assess the accuracy of double-contrast magnetic resonance (MR) imaging for the treatment response evaluation of hepatocellular carcinoma (HCC) in cirrhotic liver after transarterial chemoembolization (TACE).

Methods

Twenty-two patients with 30 HCC nodules treated by TACE underwent double-contrast MR imaging 1 month after treatment. MR images were obtained before and after the sequential administration of superparamagnetic iron oxide (SPIO) and gadopentetate dimeglumine contrast agent within the same imaging session. Two observers retrospectively assessed all treated nodules for evidence of residual viable tumor after TACE. The diagnostic performance of gadolinium-enhanced, SPIO-enhanced, and double-contrast enhanced images was calculated. Histopathological and angiographical findings served as standard of reference. Receiver operating characteristic curves and areas under the curves (A z) were calculated.

Results

Double-contrast technique (A z = 0.95) was significantly (p = 0.036) more accurate than SPIO-enhanced technique (A z = 0.92) and gadolinium-enhanced technique (p = 0.005) (A z = 0.81) in viable tumor detection after TACE. Double-contrast technique was significantly more sensitive (92%) than SPIO-enhanced technique (80%) and gadolinium-enhanced technique (68%). Kappa values for interobserver agreement ranged from 0.67 to 0.87 and were significantly different from zero (all p < 0.001).

Conclusions

Compared to gadolinium-enhanced and SPIO-enhanced techniques, double-contrast technique significantly improves the detection of viable tumor in HCC after TACE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519–524

    Article  PubMed  Google Scholar 

  2. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338

    Article  PubMed  CAS  Google Scholar 

  3. Ito K, Honjo K, Fujita T, et al. (1995) Therapeutic efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma: MRI and pathology J Comput Assist Tomogr 19:198–203

    Article  PubMed  CAS  Google Scholar 

  4. Ward J, Guthrie JA, Scott DJ, et al. (2000) Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis Radiology 216:154–162

    PubMed  CAS  Google Scholar 

  5. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC (1997) Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector Radiology 202:268–273

    PubMed  CAS  Google Scholar 

  6. Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A (1996) Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization Abdom Imaging 21:488–494

    Article  PubMed  CAS  Google Scholar 

  7. Yoshioka H, Nakagawa K, Shindou H, et al. (1990) MR imaging of the liver before and after transcatheter hepatic chemo-embolization for hepatocellular carcinoma Acta Radiol 31:63–67

    PubMed  CAS  Google Scholar 

  8. Landis JR, Koch GG (1977) An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers Biometrics 33:363–374

    Article  PubMed  CAS  Google Scholar 

  9. Imaeda T, Yamawaki Y, Seki M, et al. (1993) Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology Cardiovasc Intervent Radiol 16:209–213

    Article  PubMed  CAS  Google Scholar 

  10. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H (1994) Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate Cancer Chemother Pharmacol 33(suppl):S84–S88

    Article  PubMed  Google Scholar 

  11. Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings Radiology 182:709–713

    PubMed  CAS  Google Scholar 

  12. Kenji J, Hyodo I, Tanimizu M, et al. (1997) Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases Semin Oncol 24:S6-71–S76-80

    Google Scholar 

  13. Miller DL, O’Leary TJ, Girton M (1987) Distribution of iodized oil within the liver after hepatic arterial injection Radiology 162:849–852

    PubMed  CAS  Google Scholar 

  14. Takayasu K, Shima Y, Muramatsu Y, et al. (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163:345–351

    PubMed  CAS  Google Scholar 

  15. Takayasu K, Arii S, Matsuo N, et al. (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma AJR Am J Roentgenol 175:699–704

    PubMed  CAS  Google Scholar 

  16. Okusaka T, Okada S, Ueno H, et al. (2000) Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma Oncology 58:293–299

    Article  PubMed  CAS  Google Scholar 

  17. Nishimine K, Uchida H, Matsuo N, et al. (1994) Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results Cancer Chemother Pharmacol 33(suppl):S60–S68

    Article  PubMed  Google Scholar 

  18. Murakami R, Yoshimatsu S, Yamashita Y, Sagara K, Arakawa A, Takahashi M (1994) Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence Acta Radiol 35:576–580

    Article  PubMed  CAS  Google Scholar 

  19. Vogl TJ, Trapp M, Schroeder H, et al. (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center Radiology 214:349–357

    PubMed  CAS  Google Scholar 

  20. Minami Y, Kudo M, Kawasaki T, et al. (2003) Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography AJR Am J Roentgenol 180:703–708

    PubMed  Google Scholar 

  21. Sze DY, Razavi MK, So SK, Jeffrey RB Jr (2001) Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma AJR Am J Roentgenol 177:1339–1345

    PubMed  CAS  Google Scholar 

  22. Koito K, Namieno T, Ichimura T, et al. (2000) Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy AJR Am J Roentgenol 174:337–341

    PubMed  CAS  Google Scholar 

  23. Cioni D, Lencioni R, Bartolozzi C (2000) Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound Eur Radiol 10:1570–1575

    Article  PubMed  CAS  Google Scholar 

  24. Sumi S, Yamashita Y, Mitsuzaki K, et al. (1999) Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma AJR Am J Roentgenol 172:67–71

    PubMed  CAS  Google Scholar 

  25. Murakami T, Nakamura H, Hori S, et al. (1993) Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA. Acta Radiol 34:399–403

    PubMed  CAS  Google Scholar 

  26. Lagalla R, Caruso G, Finazzo M (1998) Monitoring treatment response with color and power Doppler Eur J Radiol 27(suppl 2):S149–S156

    Article  PubMed  Google Scholar 

  27. Youk JH, Lee JM, Kim CS (2003) Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging J Ultrasound Med 22:911–920

    PubMed  Google Scholar 

  28. Murakami T, Nakamura H, Tsuda K, et al. (1993) Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging AJR Am J Roentgenol 160:295–299

    PubMed  CAS  Google Scholar 

  29. Kubota K, Hisa N, Nishikawa T, et al. (2001) Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI Abdom Imaging 26:184–190

    Article  PubMed  CAS  Google Scholar 

  30. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R (1997) Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization Eur Radiol 7:10–16

    Article  PubMed  Google Scholar 

  31. Sakurai M, Okamura J, Kuroda C (1984) Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study Cancer 54:387–392

    Article  PubMed  CAS  Google Scholar 

  32. Marukawa T, Harada K, Kuruda C (1987) MRI of the resected hepatocellular carcinoma specimens following trans-catheter arterial embolization. Comparison with pathologic findings (Abstract). In: 5th Asian oceanian congr radiol, vol 47

  33. Yan FH, Zhou KR, Cheng JM, et al. (2002) Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE World J Gastroenterol 8:658–662

    PubMed  Google Scholar 

  34. Ohtomo K, Itai Y, Yoshikawa K, Yashiro N, Kokubo T, Iio M (1986) MR imaging of hepatoma treated by embolization J Comput Assist Tomogr 10:973–975

    Article  PubMed  CAS  Google Scholar 

  35. Noguchi Y, Murakami T, Kim T, et al. (2003) Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT AJR Am J Roentgenol 180:455–460

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Magnetic Resonance, Institute of Diagnostic Radiology, Zurich, Switzerland

    Nicolae Bolog, Thomas Pfammatter, Gustav Andreisek & Dominik Weishaupt

  2. Department of Gastroenterology, University Hospital, Zurich, Switzerland

    Beat Müllhaupt

Authors
  1. Nicolae Bolog
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Pfammatter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beat Müllhaupt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gustav Andreisek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dominik Weishaupt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dominik Weishaupt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolog, N., Pfammatter, T., Müllhaupt, B. et al. Double-contrast magnetic resonance imaging of hepatocellular carcinoma after transarterial chemoembolization. Abdom Imaging 33, 313–323 (2008). https://doi.org/10.1007/s00261-007-9244-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-007-9244-y

Key words

Search

Navigation